메뉴 건너뛰기




Volumn 22, Issue 8, 2007, Pages 1190-1198

Safety, tolerability and satisfaction with tegaserod therapy in Asia-Pacific patients with irritable bowel syndrome with constipation

(869)  Fock, K M d   Wagner, Amy b,c   Ahad, M A d   Ahmed, D S d   Ahmed, F d   Ahmed, M M d   Ali, M S d   Bhuiyan, M R d   Chowdhury, D d   Hasan, M d   Ishaqe, S M d   Kabir, A d   Khan, M R d   Masud, H d   Masud, M A d   Rab Sarkar, M A d   Rahim Mia, M A d   Rahman, M H d   Raihan, A S M A d   Rowsan, A H M d   more..

d NONE

Author keywords

Adverse events; Asia Pacific; Irritable bowel syndrome; Satisfaction; Tegaserod

Indexed keywords

CISAPRIDE; DIMETICONE; DOMPERIDONE; PINAVERIUM; TEGASEROD;

EID: 34547732956     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04955.x     Document Type: Article
Times cited : (6)

References (27)
  • 1
    • 20044364384 scopus 로고    scopus 로고
    • Irritable bowel syndrome in developing countries: A disorder of civilization or colonization?
    • Gwee KA. Irritable bowel syndrome in developing countries: a disorder of civilization or colonization? Neurogastroenterol. Motil. 2005 17 : 317 24.
    • (2005) Neurogastroenterol. Motil. , vol.17 , pp. 317-324
    • Gwee, K.A.1
  • 2
    • 84995359810 scopus 로고    scopus 로고
    • Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. Rome II. The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment; a Multinational Consensus. McLean, VA : Degnon Associates, 2000.
  • 3
    • 0033992829 scopus 로고    scopus 로고
    • Epidemiologic study of the irritable bowel syndrome in Beijing: Stratified randomized study by cluster sampling
    • Pan G, Lu S, Ke M, Han S, Guo H, Fang X. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling. Chin. Med. J. (Engl.) 2000 113 : 35 9.
    • (2000) Chin. Med. J. (Engl.) , vol.113 , pp. 35-39
    • Pan, G.1    Lu, S.2    Ke, M.3    Han, S.4    Guo, H.5    Fang, X.6
  • 4
    • 2942577352 scopus 로고    scopus 로고
    • A population-based epidemiologic study of irritable bowel syndrome in South China: Stratified randomized study by cluster sampling
    • Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment. Pharmacol. Ther. 2004 19 : 1217 24.
    • (2004) Aliment. Pharmacol. Ther. , vol.19 , pp. 1217-1224
    • Xiong, L.S.1    Chen, M.H.2    Chen, H.X.3    Xu, A.G.4    Wang, W.A.5    Hu, P.J.6
  • 6
    • 2942677359 scopus 로고    scopus 로고
    • The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community
    • Gwee KA, Wee S, Wong ML, Png DJ. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am. J. Gastroenterol. 2004 99 : 924 31.
    • (2004) Am. J. Gastroenterol. , vol.99 , pp. 924-931
    • Gwee, K.A.1    Wee, S.2    Wong, M.L.3    Png, D.J.4
  • 7
    • 0347064087 scopus 로고    scopus 로고
    • Current patterns of irritable bowel syndrome in Taiwan: The Rome II questionnaire on a Chinese population
    • Lu CL, Chen CY, Lang HC et al. Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. Aliment. Pharmacol. Ther. 2003 18 : 1159 69.
    • (2003) Aliment. Pharmacol. Ther. , vol.18 , pp. 1159-1169
    • Lu, C.L.1    Chen, C.Y.2    Lang, H.C.3
  • 8
    • 1542435325 scopus 로고    scopus 로고
    • Advances in the management of irritable bowel syndrome
    • Cash BD, Chey WD. Advances in the management of irritable bowel syndrome. Curr. Gastroenterol. Rep. 2003 5 : 468 75.
    • (2003) Curr. Gastroenterol. Rep. , vol.5 , pp. 468-475
    • Cash, B.D.1    Chey, W.D.2
  • 9
    • 0025762133 scopus 로고
    • Motility disorders in the irritable bowel syndrome
    • Lind CD. Motility disorders in the irritable bowel syndrome. Gastroenterol. Clin. North Am. 1991 20 : 279 95.
    • (1991) Gastroenterol. Clin. North Am. , vol.20 , pp. 279-295
    • Lind, C.D.1
  • 10
    • 0034926870 scopus 로고    scopus 로고
    • The role of serotonin in the pathophysiology of irritable bowel syndrome
    • Crowell MD. The role of serotonin in the pathophysiology of irritable bowel syndrome. Am. J. Manage. Care 2001 7 (8 Suppl. 2 S252 S260.
    • (2001) Am. J. Manage. Care , vol.7 , Issue.8 SUPPL. 2
    • Crowell, M.D.1
  • 11
    • 3142752169 scopus 로고    scopus 로고
    • Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord
    • Sun YN, Luo JY. Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord. World J. Gastroenterol. 2004 10 : 1830 83.
    • (2004) World J. Gastroenterol. , vol.10 , pp. 1830-1883
    • Sun, Y.N.1    Luo, J.Y.2
  • 12
    • 0037441307 scopus 로고    scopus 로고
    • Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects
    • Coffin B, Farmachidi JP, Rueegg P, Bastie A, Bouhassira D. Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects. Aliment. Pharmacol. Ther. 2003 17 : 577 85.
    • (2003) Aliment. Pharmacol. Ther. , vol.17 , pp. 577-585
    • Coffin, B.1    Farmachidi, J.P.2    Rueegg, P.3    Bastie, A.4    Bouhassira, D.5
  • 13
    • 4644293307 scopus 로고    scopus 로고
    • Tegaserod inhibits noxious rectal distention induced responses and limbic system c-Fos expression in rats with visceral hypersensitivity
    • Jiao HM, Xie PY. Tegaserod inhibits noxious rectal distention induced responses and limbic system c-Fos expression in rats with visceral hypersensitivity. World J. Gastroenterol. 2004 10 : 2836 41.
    • (2004) World J. Gastroenterol. , vol.10 , pp. 2836-2841
    • Jiao, H.M.1    Xie, P.Y.2
  • 14
    • 8744318249 scopus 로고    scopus 로고
    • The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo
    • Beattie DT, Smith JA, Marquess D et al. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br. J. Pharmacol. 2004 143 : 549 60.
    • (2004) Br. J. Pharmacol. , vol.143 , pp. 549-560
    • Beattie, D.T.1    Smith, J.A.2    Marquess, D.3
  • 15
    • 16444371517 scopus 로고    scopus 로고
    • Tegaserod is safe, well tolerated and effective in the treatment of patients with non-diarrhoea irritable bowel syndrome
    • Fried M, Beglinger C, Bobalj NG, Minor N, Coello N, Michetti P. Tegaserod is safe, well tolerated and effective in the treatment of patients with non-diarrhoea irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 2005 17 : 421 7.
    • (2005) Eur. J. Gastroenterol. Hepatol. , vol.17 , pp. 421-427
    • Fried, M.1    Beglinger, C.2    Bobalj, N.G.3    Minor, N.4    Coello, N.5    Michetti, P.6
  • 16
    • 0034794595 scopus 로고    scopus 로고
    • Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
    • Müller-Lissner SA, Fumagalli I, Bardhan KD et al. Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment. Pharmacol. Ther. 2001 15 : 1655 66.
    • (2001) Aliment. Pharmacol. Ther. , vol.15 , pp. 1655-1666
    • Müller-Lissner, S.A.1    Fumagalli, I.2    Bardhan, K.D.3
  • 17
    • 0036829638 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation
    • Novick J, Miner P, Krause R et al. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment. Pharmacol. Ther. 2002 16 : 1877 88.
    • (2002) Aliment. Pharmacol. Ther. , vol.16 , pp. 1877-1888
    • Novick, J.1    Miner, P.2    Krause, R.3
  • 18
    • 28144441586 scopus 로고    scopus 로고
    • A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation (IBS-C)
    • Tack J, Müller-Lissner S, Bytzer P et al. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation (IBS-C). Gut 2005 54 : 1707 13.
    • (2005) Gut , vol.54 , pp. 1707-1713
    • Tack, J.1    Müller-Lissner, S.2    Bytzer, P.3
  • 20
    • 0002706504 scopus 로고    scopus 로고
    • Tegaserod provides relief of symptoms in female patients with irritable bowel syndrome (IBS) suffering from abdominal pain and discomfort, bloating and constipation
    • A. 22.
    • Lefkowitz M, Ligozio G, Lebas K, Heggland JE, Rueegg PC. Tegaserod provides relief of symptoms in female patients with irritable bowel syndrome (IBS) suffering from abdominal pain and discomfort, bloating and constipation. Gastroenterology 2001 120 : 104 : A 22.
    • (2001) Gastroenterology , vol.120 , pp. 104
    • Lefkowitz, M.1    Ligozio, G.2    Lebas, K.3    Heggland, J.E.4    Rueegg, P.C.5
  • 21
    • 0037799916 scopus 로고    scopus 로고
    • An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
    • Kellow J, Lee OY, Chang FY et al. An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 2003 52 : 671 6.
    • (2003) Gut , vol.52 , pp. 671-676
    • Kellow, J.1    Lee, O.Y.2    Chang, F.Y.3
  • 23
    • 84995334192 scopus 로고    scopus 로고
    • Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE. Rome. The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment: a Multinational Consensus. McLean, VA : Degnon Associates, 1994.
  • 24
    • 3042525813 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, multicenters study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome
    • (In Chinese.)
    • Lin SR, Tegaserod Clinical Research G. [A randomized, double-blind, placebo-controlled, multicenters study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome]. Zhonghua Nei Ke Za Zhi 2003 42 : 88 90. (In Chinese.)
    • (2003) Zhonghua Nei Ke Za Zhi , vol.42 , pp. 88-90
    • Lin, S.R.1    Tegaserod Clinical Research, G.2
  • 25
    • 1842787857 scopus 로고    scopus 로고
    • Efficacy and tolerability of tegaserod in constipation dominant Irritable Bowel Syndrome
    • Shah SH, Jafri SW, Gul M et al. Efficacy and tolerability of tegaserod in constipation dominant Irritable Bowel Syndrome. J. Coll. Physicians Surg. Pak. 2004 14 : 21 4.
    • (2004) J. Coll. Physicians Surg. Pak. , vol.14 , pp. 21-24
    • Shah, S.H.1    Jafri, S.W.2    Gul, M.3
  • 26
    • 0038760669 scopus 로고    scopus 로고
    • Diarrhea in patients treated with tegaserod for irritable bowel syndrome with constipation (IBS-C) is infrequent and usually self-limited
    • Earnest D, Ruegg P, Dunger-Baldauf C, Lefkowitz M. Diarrhea in patients treated with tegaserod for irritable bowel syndrome with constipation (IBS-C) is infrequent and usually self-limited. Am. J. Gastroenterol. 2002 97 (9 Suppl. S277.
    • (2002) Am. J. Gastroenterol. , vol.97 , Issue.9 SUPPL.
    • Earnest, D.1    Ruegg, P.2    Dunger-Baldauf, C.3    Lefkowitz, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.